Skip to main content
SpringerLink
Log in

Aspirin/prasugrel/tirofiban

Decrease in haemoglobin: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Tigen MK, et al. Bleeding risk with concomitant use of tirofiban and third-generation P2Y12 receptor antagonists in patients with acute myocardial infarction: A real-life data. Anatolian Journal of Cardiology 25: 699-705, No. 10, Oct 2021. Available from: URL: http://doi.org/10.5152/AnatolJCardiol.2021.27974

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aspirin/prasugrel/tirofiban. Reactions Weekly 1881, 38 (2021). https://doi.org/10.1007/s40278-021-05247-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-05247-z

Search

Navigation